Strides Pharma Science Limited — Others, 29-11-2024: Shareholders meeting

Shareholders of Strides Pharma Science Limited have approved the re-appointment of Dr. Kausalya Santhanam as an Independent Director through a postal ballot, achieving over 87% support. The resolution received substantial backing, with 5.77 crore votes in favor and 0.79 crore against. This strategic move to retain Dr. Santhanam indicates the company’s commitment to governance and experienced leadership, potentially enhancing investor confidence. Such continuity in the boardroom may provide a positive outlook for the company, positioning it for sustained operational growth and stability in management.